WPRIM Management System> DCMS> Journal of the Korean Academy of Child and Adolescent Psychiatry> 2012> 23> Suppl

Volume: 23 Issue: Suppl

1. Discussion Meeting. Page:S90—S95
2. Treatment for Attention-Deficit/Hyperactivity Disorder in Adults. Page:S72—S89
3. Discussion Meeting. Page:S90—S95
4. Treatment of Developmental Disorders with ADHD Symptoms. Page:S66—S71
5. Treatment for Attention-Deficit/Hyperactivity Disorder in Adults. Page:S72—S89
6. Pharmacotherapy of Comorbid Disruptive Behavioral Disorders in Children and Adolescents with ADHD. Page:S55—S65
7. Treatment of Developmental Disorders with ADHD Symptoms. Page:S66—S71
8. Treatment of Comorbid Anxiety and Mood Disorder in ADHD. Page:S46—S54
9. Pharmacotherapy of Comorbid Disruptive Behavioral Disorders in Children and Adolescents with ADHD. Page:S55—S65
10. Safety and Tolerability of OROS Methylphenidate for the Treatment of ADHD. Page:S24—S45
11. Treatment of Comorbid Anxiety and Mood Disorder in ADHD. Page:S46—S54
12. Efficacy of OROS Methylphenidate for the Treatment of ADHD. Page:S12—S23
13. Safety and Tolerability of OROS Methylphenidate for the Treatment of ADHD. Page:S24—S45
14. Neurobiology of Attention-Deficit/Hyperactivity Disorder and the Action Mechanism of OROS Methylphenidate. Page:S5—S11
15. Efficacy of OROS Methylphenidate for the Treatment of ADHD. Page:S12—S23
16. Neurobiology of Attention-Deficit/Hyperactivity Disorder and the Action Mechanism of OROS Methylphenidate. Page:S5—S11

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.